scholarly journals Tumor Flare Reaction

2020 ◽  
Author(s):  
Keyword(s):  
Flare Reaction

Endogenous Opioids and Ruthenium Red Inhibit the Flare Reaction in the Pig Skin by Different Mechanisms

1991 ◽  
Vol 632 (1 Substance P a) ◽  
pp. 460-463 ◽  
Author(s):  
FR-K. PIERAU ◽  
R. ERNST ◽  
H. SANN ◽  
L. BARTHÓ
Keyword(s):  
Ruthenium Red ◽  
Endogenous Opioids ◽  
Pig Skin ◽  
Flare Reaction

Tumor Lysis Syndrome/Tumor Flare Reaction in Lenalidomide-Treated Chronic Lymphocytic Leukemia

2007 ◽  
Vol 25 (31) ◽  
pp. 5047-5047 ◽  
Author(s):  
Laure A. Moutouh-de Parseval ◽  
Lilia Weiss ◽  
Robert J. DeLap ◽  
Robert D. Knight ◽  
Jerome B. Zeldis
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Tumor Lysis Syndrome ◽  
Lymphocytic Leukemia ◽  
Tumor Lysis ◽  
Flare Reaction

Allergic Diseases

2016 ◽  
pp. 3-14
Author(s):  
Gerald W. Volcheck
Keyword(s):  
Allergic Diseases ◽  
Scientific Basis ◽  
Testing Methods ◽  
Blood Testing ◽  
Allergy Testing ◽  
Skin Prick Tests ◽  
Flare Reaction ◽  
Wheal And Flare

Standard allergy testing relies on identifying the immunoglobulin (Ig) E antibody specific for the allergen in question. Two classic methods of doing this are the immediate wheal-and-flare skin prick tests (in which a small amount of antigen is introduced into the skin and the site is evaluated after 15 minutes for the presence of an immediate wheal-and-flare reaction) and in vitro (blood) testing. Methods of allergy testing that do not have a clear scientific basis include cytotoxic testing, provocation-neutralization testing or treatment, and “yeast allergy” testing.

The Effects of Intradermal Fentanyl and Ketamine on Capsaicin-Induced Secondary Hyperalgesia and Flare Reaction

1999 ◽  
Vol 89 (6) ◽  
pp. 1521
Author(s):  
Wolfgang Koppert ◽  
Susanne Zeck ◽  
James A. Blunk ◽  
Martin Schmelz ◽  
Rudolf Likar ◽  
...  
Keyword(s):  
Secondary Hyperalgesia ◽  
Flare Reaction

scholarly journals H1-antihistamines suppress wheal-and-flare reaction and skin blood perfusion measured by Laser Dopppler flowmetry: randomized, double-blind, placebo-controlled, crossover design study

2010 ◽  
Vol 64 (5-6) ◽  
pp. 175-181
Author(s):  
Māris Bukovskis ◽  
Madara Tirzīte ◽  
Gunta Strazda ◽  
Normunds Jurka ◽  
Renāte Ligere ◽  
...  
Keyword(s):  
Blood Perfusion ◽  
Sedative Effect ◽  
Crossover Design ◽  
Design Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Skin Blood Perfusion ◽  
H1 Antihistamines ◽  
Flare Reaction ◽  
Wheal And Flare

H1-antihistamines suppress wheal-and-flare reaction and skin blood perfusion measured by Laser Dopppler flowmetry: randomized, double-blind, placebo-controlled, crossover design study The aim of our study was to compare the influence of pre-treatment with H1-antihistamines (levocetirizine, desloratadine, clemastine, quifenadine, and sequifenadine) and a placebo on the histamine-induced weal and flare reaction, increase of skin blood perfusion and sedation. Thirty healthy volunteers were enrolled in the study. The study design was a prospective, randomised, double-blind, placebo-controlled, crossover, balanced clinical trial. Volunteers in randomised and double-blind order were treated with oral levocetirizine 5 mg, desloratadine 5 mg, clemastine 1 mg, quifenadine 50 mg, sequifenadine 50 mg or a placebo. Two hours after intake of medication, the histamine skin prick test was performed and skin blood perfusion was registered with further evaluation of sedative effect. We conclude that levocetirizine induced a significant and pronounced decrease of weal and flare reaction and skin blood perfusion compared to the placebo and the other H1-antihistamines. The effect of quifenadine and sequifenadine on weal reaction area was similar to desloratadine and clemastine. Regarding the sedative effect, we can conclude that second generation antihistamines appear to be not non-sedative but the least impairing, and the first generation antihistamines appear to be the most impairing on central nervous system function. There is a necessity to consider the sedating potential of antihistamines, along with other factors such as efficacy, when prescribing antihistamines to patients.

Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome

Blood ◽  
2014 ◽  
Vol 123 (8) ◽  
pp. 1159-1166 ◽  
Author(s):  
Christiane Querfeld ◽  
Steven T. Rosen ◽  
Joan Guitart ◽  
Madeleine Duvic ◽  
Youn H. Kim ◽  
...  
Keyword(s):  
Disease Burden ◽  
Overall Response Rate ◽  
Response Rate ◽  
Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Open Label ◽  
Phase 2 Trial ◽  
Multicenter Phase ◽  
Key Points ◽  
Flare Reaction

Key Points Lenalidomide is effective in refractory advanced cutaneous T-cell lymphoma, with an overall response rate of 28%. Patients demonstrate a transient flare reaction in skin, blood, and/or lymph nodes that may be associated with improvement in disease burden.

Extra-Articular Steroid Injection: Early Patient Response and the Incidence of Flare Reaction

2007 ◽  
Vol 32 (10) ◽  
pp. 1513-1520 ◽  
Author(s):  
Charles A. Goldfarb ◽  
Richard H. Gelberman ◽  
Kathleen McKeon ◽  
Ben Chia ◽  
Martin I. Boyer
Keyword(s):  
Steroid Injection ◽  
Patient Response ◽  
Flare Reaction
Sign in / Sign up

Export Citation Format

Share Document